The mTOR Signaling Pathway: Key Regulator and Therapeutic Target for Heart Disease
Heart disease, including myocardial infarction, heart failure, cardiac hypertrophy, and cardiomyopathy, remains a leading cause of mortality worldwide. The mammalian target of rapamycin (mTOR) is a centrally regulated kinase that governs key cellular processes, including growth, proliferation, metab...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2025-02-01
|
| Серии: | Biomedicines |
| Предметы: | |
| Online-ссылка: | https://www.mdpi.com/2227-9059/13/2/397 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|